Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chacruna Institute to host community conversation about CA SB 519

On August 25, 2021, California Senate Bill 519 (SB519) was paused in the CA State Assembly Appropriations Committee. Being the first and most expansive psychedelic decriminalization bill to go through a state legislature, SB519 was a controversial bill. At 12pm Pacific on Wednesday, September 8, Chacruna Institute is hosting What's Happening with the CA Decriminalization Bill? Community Learning from the Advocacy Front Lines, a moderated community forum about the ins and outs of the bill, from its origin, to the negotiations and compromises, to its current status and next steps. This forum is supported by over 25 advocacy and educational organizations in the psychedelic space.


News provided by

Chacruna Institute

Sep 02, 2021, 17:45 ET

Share this article

Share toX

Share this article

Share toX

What’s Happening with the CA Decriminalization Bill? Community Learning from the Advocacy Front Lines
What’s Happening with the CA Decriminalization Bill? Community Learning from the Advocacy Front Lines

SAN FRANCISCO, Sept. 2, 2021 /PRNewswire-PRWeb/ -- "A group of 25 of the main grassroots, advocacy and non-profit organizations in the psychedelic space got together in this community forum to understand where we are at with SB519... to dream together, and co-create a better future for our beloved sacred plants," says Bia Labate, Executive Director, Chacruna Institute.

The legislative process is notoriously archaic and complex, yet understanding it is crucial to support and advocate for effective drug policy reform. Join community advocates and allies in a dynamic discussion to demystify SB519, a bill to decriminalize the personal use of some psychedelics that is going through the California state legislature. Chacruna has previously published an article by Sean McAllister, one of nation's leading drug policy reform lawyers, but more open conversation is warranted.

Having conversations around policy and reform that is accessible to the greater community is imperative to the policy process—they should be as transparent and accessible to the community as possible so we may collectively come together for true policy change.

Post this

"Having conversations around policy and reform that is accessible to the greater community is imperative to the policy process—they should be as transparent and accessible to the community as possible so we may collectively come together for true policy change." --Monica Cadena, Co-Executive Director of the Society for Psychedelic Outreach, Reform, and Education (SPORE)

This panel will cover:

  • The origins of the bill - what inspired Senator Wiener to bring this issue forward in the CA legislature?
  • The negotiations and compromises - what were the boundaries and parameters that advocates were working within, and how were they navigated by the advocates and coalitions supporting its passage? For example, why was ketamine excluded, and how did the discussion evolve around personal threshold limits, and provisions for group support?
  • Future prospects - what happens next, whether or not it is passed into law?
  • Why are legislative changes in California so important, and how this might affect the rest of the country and world?

We are grateful that CA Senator Scott Wiener, sponsor and original drafter of SB519, will send a pre-recorded video which will be broadcasted at the beginning of the event.

"As a community organizer I believe in people power. I also believe that the best way to harness people power is through us being well and accurately informed. Oakland Hyphae believes that it is critical that the public have the ability to ask questions and give input to those shaping the future of plant medicine. This forum and forums is meant to elevate the voice of the people as well as connect them to the process." --Reggie Harris, HNIC at Oakland Hyphae

Because the bill was recently paused until next year, panelists will discuss lessons learned and what to prepare for when the session continues in 2022. Particular attention will be paid to providing clarity around community concerns in a moderated Q&A.

"I'm hopeful to see such dedicated advocates in conversation with communities in this forum. My hope is that together we are growing an accurately informed and caring community aligned towards effective and equitable decriminalization." --Bob Otis, Garden Steward for Sacred Garden Community

What's Happening with the CA Decriminalization Bill? Community Learning from the Advocacy Front Lines: A Conversation with Ismail Ali, David Bronner, Reggie Harris and Monica Cadena will take place on Wednesday, September 8th from 12-2pm PST. To register, click here.

This event is proudly co-produced by Chacruna, San Francisco Psychedelic Society, SPORE and Oakland Hyphae with the support of the following Community Sponsors:

  • Decriminalize Nature Eugene
  • Decriminalize Nature Seattle
  • Fireside Project
  • Heroic Hearts Project
  • Los Angeles Medicinal Psychedelic Society
  • Lucid News
  • MAPS
  • Petrie-Flom Center for Health, Law, Biotechnology, and Bioethics at Harvard Law School
  • Plant Medicine Coalition
  • Plant Medicine Healing Alliance
  • Psychedelic and Entheogen Academic Council
  • Psychedelic Seminars
  • Psychedelic Support
  • Psychedelic Times
  • Psychedelics Today
  • Sacred Garden Community
  • Sage Institute
  • Students for Sensible Drug Policy
  • Tam Integration
  • Unlimited Sciences
  • Vote Nature

About Chacruna Institute                                
The Chacruna Institute for Psychedelic Plant Medicines, an organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist Dr. Clancy Cavnar, produces high-quality research on plant medicines and psychedelics and helps propagate academic knowledge in more accessible formats. We educate the public and create cultural understanding and legitimacy regarding these substances so that they may cease to be stigmatized and outlawed. Chacruna also promotes a bridge between the world of plant medicines and the emergent field of psychedelic science, between "traditional ceremonial use" and clinical and therapeutic settings, bringing the knowledge and perspectives of the social sciences to health care professionals and practitioners of psychedelic-assisted therapy. Finally, we foster cultural and political reflections on the field of psychedelic science and facilitate conversations about controversial topics that have been simmering on the sidelines as psychedelics go mainstream.

Media Contact

Brystal Karber, Chacruna Institute, +1 415-390-6157, [email protected]

Twitter, Facebook

SOURCE Chacruna Institute

Related Links

http://chacruna.net/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.